№ files_lp_3_process_9_24052
File format: docx
Character count: 1457
File size: 16 KB
This document is a health advisory updating physicians on the safety concerns regarding the Johnson & Johnson COVID-19 vaccine, including rare cases of cerebral venous sinus thrombosis and thrombocytopenia, and recommendations for continued monitoring.
Year:
2021
Region / City:
United States
Topic:
COVID-19 Vaccine, Safety Monitoring
Document Type:
Health Advisory
Organization:
American College of Physicians
Author:
Laura Baldwin
Target Audience:
Healthcare Providers
Date of Issue:
April 15, 2021
Date of Updates:
April 15, 2021
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / city:
Mississippi
Topic:
Church ministry, annual reporting
Document type:
Instructions
Organization:
MBCB (Mississippi Baptist Convention Board)
Author:
Vesta Clary
Target audience:
Church ministry assistants, secretaries, church clerks
Period of validity:
Annual, for the year 2024
Approval date:
Not specified
Date of changes:
Not specified
Year:
Not specified
Region / City:
Not specified
Subject:
Arterial line insertion
Document type:
Competence assessment
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Healthcare practitioners (ANP / ACP / SCP)
Validity period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2024
Region / City:
Mississippi
Topic:
Church Information Collection
Document Type:
Instruction Manual
Organization / Institution:
MBCB (Mississippi Baptist Convention Board)
Author:
Vesta Clary
Target Audience:
Church Administrators
Effective Period:
2024
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Caribbean
Theme:
Water, Environment, Development
Document Type:
Proposal
Organization / Institution:
Global Water Partnership-Caribbean (GWP-C), United Nations Environment Programme (UNEP), Cartagena Convention Secretariat
Author:
Not specified
Target Audience:
Partners, Project Implementers, Stakeholders in Caribbean Region
Implementation Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
South London
Topic:
Healthcare, Primary and Urgent Care
Document Type:
Job Description
Organization:
SELDOC
Author:
Human Resources Department
Target Audience:
Healthcare professionals with advanced clinical qualifications
Employment Type:
Full-Time/Part-Time
Salary:
Up to £79 per hour, depending on experience and location
Qualifications Required:
Registration with relevant professional body, non-medical prescribing qualification, postgraduate qualification in advanced practice
Experience Required:
Autonomous clinical practice, primary or urgent care experience, paediatrics including children under 2 years, mental health assessment
Skills:
Clinical reasoning, communication, teamwork, knowledge of referral pathways, use of healthcare technology
Application Contact:
[email protected]
Equal Opportunities:
Yes
Year:
2019
Location:
Hawai‘i Pacific Health, Learning Resource Center, Room 101, 793 S Hotel Street (Next to Straub Medical Center)
Topic:
Advance Care Planning, Advance Directives, POLST
Document Type:
Training Course
Organization:
Hawai‘i Pacific Health
Author:
Hawai‘i Pacific Health ACP Coordinator, Michelle Cantillo
Target Audience:
Nurses, Physicians, Social Workers, Clinicians
Event Dates:
February 26, 2019; May 14, 2019; August 21, 2019; December 11, 2019
Approval Date:
N/A
Change Date:
N/A
Document Title:
Trainee ACP – Commissioning Information for SY&B Managers
First Published:
March 2019
Revision:
Version 4
Due for Review:
January 2022
Region:
South Yorkshire & Bassetlaw
Country:
United Kingdom
Subject Area:
Advanced Clinical Practice training and workforce development
Document Type:
Commissioning guidance and organisational information
Sponsoring Organisation:
South Yorkshire & Bassetlaw Faculty for Advanced Clinical Practice (FACP)
Contributing Organisations:
Health Education England; Sheffield Teaching Hospitals
Adapted From:
GP ACP Ready Pack; Commissioning Information for Managers in Sheffield Teaching Hospitals 2021–2022
Authors of Source Materials:
Jo Mirza; Suzanne Owens; Helen Atkinson
Target Audience:
Managers and organisational leads responsible for workforce planning and training
Programme Referenced:
Trainee Advanced Clinical Practitioner Masters Programme
Relevant Institutions:
University of Sheffield; Sheffield Hallam University
Funding Mechanism:
Apprenticeship Levy with supplementary training grants from Health Education England
Applicable Professions:
Nurses, physiotherapists, pharmacists, radiographers, paramedics, and other registered healthcare professionals
Application Period Referenced:
2021–2022 academic year
Note:
Year
Topic:
Vaccination Consent
Document Type:
Consent Form
Target Audience:
Patients, Healthcare Providers
Year:
2025
Region / city:
England
Topic:
Immunization
Document type:
Patient Group Direction (PGD)
Organization / institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Professor Shamez Ladhani, David Green
Target audience:
Healthcare professionals involved in immunization
Period of validity:
From 5 January 2026 to 5 January 2029
Approval date:
5 January 2026
Amendment date:
2 June 2025, 16 December 2025
Description:
A document detailing the administration guidelines for the pneumococcal polysaccharide conjugate vaccine (PCV13, PCV15) for children under 2 years old in the UK.
Year:
2025
Region / City:
London
Topic:
Neonatal BCG vaccination program
Document Type:
Protocol
Organization / Institution:
NHSE
Author:
Alice Waters
Target Audience:
Healthcare professionals involved in neonatal care and immunization
Period of validity:
Not specified
Approval Date:
Not specified
Date of changes:
September 2025
Year:
2023
Region / City:
N/A
Subject:
Vaccination
Document Type:
Medical Guidelines
Organization / Institution:
Merck
Author:
N/A
Target Audience:
Healthcare professionals
Effective Period:
N/A
Approval Date:
07/13/2015
Revision Dates:
07/13/2015, 11/15/2015, 06/2016, 04/2023, 08/2024
Year:
2025
Region / city:
United Kingdom
Subject:
COVID-19 vaccination
Document type:
Protocol
Institution:
UK Health Security Agency (UKHSA)
Author:
UK Health Security Agency (UKHSA)
Target audience:
Healthcare providers involved in COVID-19 vaccination
Period of validity:
1 October 2025 – 31 January 2026
Approval date:
12 September 2025
Note:
Revision history
Year:
2025
Region / city:
[insert local health board name]
Theme:
Vaccination
Document type:
Patient Group Direction (PGD)
Authorising organisation:
NHS Wales
Target audience:
Healthcare professionals (Registered)
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
07 August 2025
Amendment date:
30 June 2025
Review date:
01 July 2026
Expiry date:
31 March 2026
Year:
2025
Region / city:
England
Topic:
Influenza immunisation
Document type:
Patient Group Direction (PGD)
Organisation:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Jamie Lopez-Bernal, Greta Hayward
Target audience:
Healthcare practitioners, NHS organisations
Period of validity:
From 1 September 2025 to 1 April 2026
Approval date:
3 July 2025
Revision history:
Updated annually, latest update 9 July 2025
Reference no:
HPV (GBMSM) PGD
Version no:
v5.0
Valid from:
1 September 2025
Review date:
1 April 2028
Expiry date:
1 September 2028
Author:
Suki Hunjunt, Sharif Ismail, David Green
Region / city:
England
Target audience:
Healthcare practitioners administering HPV vaccine to GBMSM
Type of document:
Patient Group Direction
Organisation:
UK Health Security Agency (UKHSA)
Date of approval:
17 July 2025
Date of modifications:
16 July 2025
Context:
A formal Patient Group Direction for the administration of HPV vaccine to GBMSM, detailing legal, clinical, and procedural requirements for healthcare practitioners in England.
Reference no:
Hib/MenC PGD
Version no:
v6.0
Valid from:
1 July 2025
Expiry date:
30 April 2026
Authorising organisations:
UK Health Security Agency (UKHSA)
Target audience:
Registered healthcare practitioners
Responsible body:
UKHSA
Note:
Amendment history
v1.0 and v2.0:
See previous versions of this PGD template for details (19 January 2016 to 23 April 2018)
v3.0:
PHE Hib/MenC PGD amended to: include vaccination of individuals for the prevention of secondary cases of meningococcal group C disease (24 April 2018)
v4.0:
PHE Hib/MenC PGD amended to: remove reference to individuals with an underlying medical condition (5 March 2020)
v5.0:
UKHSA Hib/MenC PGD amended to: include minor rewording of standard text, layout and formatting changes (4 May 2022)
v6.0:
UKHSA Hib/MenC PGD amended to: include minor rewording, updated references, and changes to the childhood immunisation schedule (2 June 2025)
Developed by:
Christina Wilson (Lead Pharmacist), Professor Shamez Ladhani (Paediatric Infectious Diseases Consultant), David Green (Nurse Consultant for Immunisation Programmes)
Peer-reviewed by:
UKHSA Immunisations PGD Expert Panel
Date approved:
2 June 2025
Year:
2025
Region / city:
Global
Topic:
Vaccine Policy, Maternal Health, Group B Streptococcus
Document type:
WHO Guidance
Institution:
World Health Organization (WHO)
Author:
WHO ECVP
Target audience:
Policymakers, Vaccine Developers, Public Health Authorities
Period of validity:
Ongoing
Approval date:
March 11, 2025
Date of changes:
Not specified
Year:
2025
Region:
England
Subject:
Hepatitis B vaccination for renal patients
Document Type:
Patient Group Direction (PGD)
Authorising Organisation:
UK Health Security Agency (UKHSA)
Target Audience:
Registered healthcare professionals
Period of Validity:
28 February 2025 - 28 February 2028
Approval Date:
28 February 2025
Amendment Date:
21 February 2025
Year:
2024
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction
Organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr. Mary Ramsay, David Green
Target audience:
Registered healthcare practitioners
Period of validity:
10 October 2024 - 30 April 2027
Approval date:
4 October 2024
Amendments date:
9 October 2024
Year:
2018
Region / City:
Oregon
Theme:
Vaccine Replacement, Immunization Policy
Document Type:
Policy
Organization:
Oregon Immunization Program (OIP)
Target Audience:
VFC program organizations, Healthcare providers
Period of Action:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified